PathAI Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
268
- Latest Deal Type
-
M&A
- (Announced)
- Latest Deal Amount
-
$1.05B
- Investors
-
26
PathAI General Information
Description
Operator of a pathology platform designed to facilitate tissue analysis and drug development. The company utilizes machine learning algorithms, image processing software, and data management systems, enabling drug manufacturers and health organizations to identify disease biomarkers, evaluate slide images, and execute research trials.
Contact Information
Website
www.pathai.comCorporate Office
- 1325 Boylston Street
- Suite 10000
- Boston, MA 02215
- United States
Corporate Office
- 1325 Boylston Street
- Suite 10000
- Boston, MA 02215
- United States
PathAI Timeline
PathAI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Merger/Acquisition | 06-May-2026 | $1.05B | Announced | Generating Revenue | ||
| 9. Debt - General | 01-Jan-2025 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 7. Mezzanine | 23-Dec-2022 | Completed | Generating Revenue | |||
| 6. Debt - General | 01-Jan-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 18-May-2021 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 04-Nov-2019 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 23-Jul-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-May-2018 | $15M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 31-Oct-2017 | $15M | $15M | Completed | Startup |
PathAI Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A4 | ||||||||
| Series A3 | ||||||||
| Series A2 | ||||||||
| Series A1 | 2,168,963 | $0.000100 | 6% | $1.76 | $1.76 | 1x | $1.76 | 6.3% |
| Series A | 3,449,295 | $0.000100 | 6% | $3.25 | $3.25 | 1x | $3.25 | 10.03% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
PathAI Comparisons
Industry
Financing
Details
PathAI Competitors (12)
One of PathAI’s 12 competitors is Inspirata, a Private Debt Financed company based in Tampa, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inspirata | Private Debt Financed | Tampa, FL | ||||
| Paige | Formerly VC-backed | New York, NY | ||||
| CureMetrix | Venture Capital-Backed | San Diego, CA | ||||
| Decipher Urologic Cancers | Formerly VC-backed | San Diego, CA | ||||
| Proscia | Formerly VC-backed | Philadelphia, PA |
PathAI Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
PathAI Patents
PathAI Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260229360-A1 | Ai-based software tool for assisting the review of dermatopathology specimens | Pending | 03-Feb-2025 | ||
| WO-2026165505-A1 | Ai-based software tool for assisting the review of dermatopathology specimens | Pending | 03-Feb-2025 | ||
| US-20260228892-A1 | Automated orientation of a histopathology image to prepare it for optimal review by a human | Pending | 03-Feb-2025 | ||
| US-20260228893-A1 | Conformal prediction techniques to classify histopathology images based on possible diagnostic entities, with calibrated confidence levels | Pending | 03-Feb-2025 | ||
| US-12793220-B2 | Multi-resolution foundation model for pathology | Active | 25-Apr-2024 | G06T7/0012 |
PathAI Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PathAI Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hercules Capital (San Mateo) | Lender/Debt Provider | Minority | ||
| Biospring Partners | Growth/Expansion | Minority | ||
| Brightwing Capital | Venture Capital | Minority | ||
| Camford Capital | Venture Capital | Minority | ||
| D1 Capital Partners | Hedge Fund | Minority |
PathAI Investments & Acquisitions (2)
PathAI’s most recent deal was a Seed Round with Bluejay (Business/Productivity Software) for . The deal was made on 27-Aug-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bluejay (Business/Productivity Software) | 27-Aug-2025 | Seed Round | Business/Productivity Software | ||
| Poplar Healthcare | 26-Jul-2021 | Merger/Acquisition | Laboratory Services (Healthcare) |
PathAI FAQs
-
When was PathAI founded?
PathAI was founded in 2016.
-
Where is PathAI headquartered?
PathAI is headquartered in Boston, MA.
-
What is the size of PathAI?
PathAI has 268 total employees.
-
What industry is PathAI in?
PathAI’s primary industry is Laboratory Services (Healthcare).
-
Is PathAI a private or public company?
PathAI is a Private company.
-
What is the current valuation of PathAI?
The current valuation of PathAI is .
-
What is PathAI’s current revenue?
The current revenue for PathAI is .
-
How much funding has PathAI raised over time?
PathAI has raised $490M.
-
Who are PathAI’s investors?
Hercules Capital (San Mateo), Biospring Partners, Brightwing Capital, Camford Capital, and D1 Capital Partners are 5 of 26 investors who have invested in PathAI.
-
Who are PathAI’s competitors?
Inspirata, Paige, CureMetrix, Decipher Urologic Cancers, and Proscia are some of the 12 competitors of PathAI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
